semaglutide eye stroke Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds | Health Semaglutide linked to higher risk

Mounjaro is only approved to treat type 2 diabetes

Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists

Japan Market Poised for Steady Growth Amid Aging Population and Rising Diabetes Burden The Japan GLP-1 receptor agonist market is expected to grow steadily during the forecast period, driven by a rising elderly population and a high prevalence of type 2 diabetes

Why You Shouldn't Take GLP-1 Weight Loss Drugs Without Medical Supervision Posted on April 20, 2026 at 11:25 AM by Iowa Weight Loss Specialists GLP-1 medications like Ozempic and Wegovy are radically changing how people approach weight loss